1
Winning at Weight LossWinning at Weight Loss
Fatless®
2
Fatless®Honi l
Carbohydrates and Weight Gain
• Carbohydrate consumption has increased over the years as fat intake has decreased.
• Obesity and diabetes rates have risen along with carbohydrate consumption.
• A typical Western diet provides:– 200-300g carbohydrates/day
– 900-1350 calories
– 49% of total calories from carbohydrates
• Blocking the conversion of carbohydrates into glucose can reduce fat storage and promote weight loss.
3
Fatless®Honi l
“Potatoes, eaten in large quantities
by a population increasingly
sedentary and overweight, may be
a major contributor to America’s
alarming rates of heart disease and diabetes.”
Time Magazine, Jan. 21, 2002
“10 Foods That Pack A Wallop”
4
Fatless®Honi l
“This is not just a potato
problem. It’s also a
problem with white bread,
bagels, and most white rice.”
Time Magazine, Jan. 21, 2002
“10 Foods That Pack A Wallop”
5
Fatless®Honi l
Carbohydrates and Weight Gain
Pancreas produces alpha amylase,a starch-digesting enzyme
Alpha amylase converts starchinto glucose (sugar)
Sugar calories are burned or stored as fat cells
Stomach
Pancreas
LiverLiver
SmallIntestineSmallIntestine
6
Fatless®Honi l
Foods Containing Starchy Carbohydrates
• Potatoes• Pasta• Bread • Rice• Grain
Refined and processed grains have a high glycemic index
7
Fatless®Honi l
Health Risks of Obesity
• Hypertension• Hyperlipidemia• Coronary Artery Disease and Stroke• Type 2 Diabetes• Respiratory Disease (sleep apnea)• Osteoarthritis• Gallbladder disease• Cancer (breast, prostate, colon)• Premature Death!
8
Fatless®Honi l
Why Is The Incidence Rising?
• Lack of physical activity
• Poor dietary choices (convenience foods)– Fast food, processed food, and sugar rather than whole
grains and vegetables
• Increased caloric intake– Increased consumption of grains, soft drinks (sugar)
and alchohol1
Center for Nutrition Policy and Promotion, USDA, 2001
9
Fatless®Honi l
Many People Need A Kick Start
• Lifestyle Coach
• Dietitian
• Nutritional Supplements
• Prescriptions Drugs (for severe cases)
10
Fatless®Honi l
• The first clinically studied starch neutralizer
• Standardized extract made from a portion of the white kidney bean
• Fatless® may bind with alpha amylase, “neutralizing” starch calories and preventing the conversion into glucose (sugar)
11
Fatless®Honi l
In Vitro Studies
• One gram of Fatless® will “neutralize the starch calories of 1 lb. pasta or 1 loaf bread
• High Activity Fatless® : 5,000 – 6,000 units/gNon-standardized bean "starch blocker”:0-540 units/g
• No trypsin/protein inhibitor activity detected
• Survives undiluted gastric and intestinal solutions (68-80% retention of activity)
12
Fatless®Honi l
Human Studies1. “In Vivo Effectiveness of a Starch Absorption Blocker in a Double-Blind
Placebo-Controlled Study with Normal Human Subjects.” Joe A. Vinson, PhD, University of Scranton, September/2001
2. “In Vivo Effectiveness of a Starch Absorption Blocker in a Double-Blind Placebo-Controlled Study with Normal College-Age Subjects.” Joe A. Vinson, PhD, University of Scranton, November/2001
3. “Evaluation of the Safety and Efficacy of a Food Supplement for Weight Control Through the Reduced Calories Intake from Carbohydrates vs Placebo (Double Blind Test).” Dr. R. Ballerini, EVIC Italia, November/2001
4. “Dose-Response Pilot Study of PHASEOUT efficacy as an inhibitor of glucose absorption with a Full Meal.” Joe A. Vinson, PhD, University of Scranton, May 2002.
5. “Phaseolamin 2250™ (Phaseolus vulgaris) for the Treatment of Obesity.” Jay Udani, MD, Northridge Hospital, 2002
6. “Dose Response Human Study of Amylase Inactivator with Normal Subjects Given a Full Meal.” Joe A. Vinson, PhD, University of Scranton, 2002
13
Fatless®Honi l
• 60 subjects, ages 25-45 (male & female, 5-15 kg overweight, stable for 30 days prior to study)
• Double-blind, placebo-controlled study for 30 days
• Recommended diet with daily consumption of complex carbohydrates during one of the principal meals
• Experimental: Placebo plus 500 mg of a Fatless® containing product.
• Changes in weight; fat and lean body mass (bioelectric impedance); waist, hip, and thigh circumference
Dr. R. Ballerini, EVIC, Milan, Italy, November/2001
Weight Loss Study
14
Fatless®Honi l
Results – Ballerini Study
Fatless® Placebo
Weight -2,933 kg -0.348 kg
-6.45 lbs -0.76 lbs
-3.96% TBW -0.47%
TBW
Fat Body Mass -10.45% -1.30%
Lean Body Mass 0.0% 0.0%
Hip Circumference -1.39% -0.10%
Thigh Circumference -1.44% -0.39%
Waistline Circumference -3.44% -0.53%
15
Fatless®Honi l
NORTHRIDGE HOSPITAL
• Randomized, Double-Blind, Placebo Controlled• 50 Patients
– Obese (35 > BMI > 30)– Age < 50– Based on Statistical Effect Size Calculation
• 8 week active study• 1500mg of Fatless® or Placebo
Approved by Human Use and Research Committee
16
Fatless®Honi l
Overall Results
Fatless®
• 3.8 pounds• 1.5 inches off waist• 26 point drop TG• 13% energy• Reduced hunger
Placebo• 1.1 pounds• No loss of inches• 8 point drop TG• No effect on energy or
hunger
17
Fatless®Honi l
• Natural, standardized extract with the first demonstration of effectiveness in human studies
• Safe, non-stimulant carbohydrate control mechanism that blocks carbohydrate conversion to sugar calories
• Reduces starch absorption by an average of 57%
• Produces weight loss by reduction of body fat mass
• No known adverse side effects or drug interactions
• Reasonable effective doses (500-1,500 mg/meal)
Summary
18
The bottom line…
Healthy eating and physical activity are essential for weight management.
